📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Use of Affimer technology for inhibition of a2-antiplasmin and enhancement of fibrinolysis. (2025)

First Author: Pechlivani N

Attributed to: Fibrinogen-targeted conformational proteins for identification of the mechanistic pathways controlling fibrin network stability funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/bloodadvances.2024014235

PubMed Identifier: 39504559

Publication URI: http://europepmc.org/abstract/MED/39504559

Type: Journal Article/Review

Volume: 9

Parent Publication: Blood advances

Issue: 1

ISSN: 2473-9529